- Home
- STAF vs GLMD Comparison
STAF vs GLMD Comparison
Compare STAF & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAF
- GLMD
- Stock Information
- Founded
- STAF 2009
- GLMD 2000
- Country
- STAF United States
- GLMD Israel
- Employees
- STAF N/A
- GLMD N/A
- Industry
- STAF Professional Services
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- STAF Consumer Discretionary
- GLMD Health Care
- Exchange
- STAF Nasdaq
- GLMD Nasdaq
- Market Cap
- STAF 1.6M
- GLMD 1.7M
- IPO Year
- STAF N/A
- GLMD 2014
- Fundamental
- Price
- STAF $1.54
- GLMD $4.09
- Analyst Decision
- STAF
- GLMD
- Analyst Count
- STAF 0
- GLMD 0
- Target Price
- STAF N/A
- GLMD N/A
- AVG Volume (30 Days)
- STAF 4.0M
- GLMD 209.3K
- Earning Date
- STAF 08-12-2024
- GLMD 09-24-2024
- Dividend Yield
- STAF N/A
- GLMD N/A
- EPS Growth
- STAF N/A
- GLMD N/A
- EPS
- STAF N/A
- GLMD N/A
- Revenue
- STAF $180,258,000.00
- GLMD N/A
- Revenue This Year
- STAF $1.94
- GLMD N/A
- Revenue Next Year
- STAF $8.38
- GLMD N/A
- P/E Ratio
- STAF N/A
- GLMD N/A
- Revenue Growth
- STAF 4.69
- GLMD N/A
- 52 Week Low
- STAF $1.08
- GLMD $2.73
- 52 Week High
- STAF $7.60
- GLMD $10.50
- Technical
- Relative Strength Index (RSI)
- STAF 43.28
- GLMD 55.94
- Support Level
- STAF $1.32
- GLMD $2.73
- Resistance Level
- STAF $1.99
- GLMD $4.44
- Average True Range (ATR)
- STAF 0.23
- GLMD 0.50
- MACD
- STAF -0.07
- GLMD 0.09
- Stochastic Oscillator
- STAF 20.90
- GLMD 73.18
About STAF Staffing 360 Solutions Inc. (DE)
Staffing 360 Solutions Inc operates in the international staffing sector. It is engaged in the execution of an international buy-integrate-build process through the acquisition of domestic and international staffing organizations. The company operates through three Business Streams: Professional Staffing, Commercial Staffing, and Employer of Record. It primarily supports accounting and finance, information technology, engineering, administration, and commercial disciplines.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.